HemeOnc Flashcards
bradykinin
vasodilates art, constricts vv, incrs permeability, incrs pain
-incrs brady when no C1 esterase inhib (high brady when low C1)
c1 Esterase inhib
incrs C1
-blocks kallikrein
direct Xa inhib (anticoags)
apiXaban, rivaroXaban, fondaparinuX
direct THROMBIN inhibs
argatroban, bivalirudin, dabigatran
prothrombin——–+?——>thrombin
factor Va
Plasminogen——+/- (tpa)—->plasmin
+ :thrombolytics: altepase, reteplase, streptokinase
- :Aminocaproic acid
no clinically signif bleeding
factor12 deficiency
req. Ca2+ and phospholipid
factors 8a, 5a, 7—->7a
first abnormal factor in liver dz
7
Acanthocyte/spur cell
liver dz, abetalipoproteinemia, chol. dysreg.
degmacyte/bite cell
G6PD def
where is excess iron in a sideroblast
mito
schistocyte/helmet
DIC, TTP/HUS, HELLP, uremia, pyruvate kinase def
malignant skin cancers
melanoma, basal cell
clonality of B lymphoctyes
determined by Ig light chain (light chain either Kappa or Lambda)
screening
catches dysplasia (reversible)
Arsennic/cig smoke
Sqaumous cell carc, lung cancer, angiosarcoma of the liver
angiosarcoma of the liver
arsenic, vinyl chloride
EBV in a chinese/african male
nasopharyngeal carc, burkitt, CNS lymphoma in AIDS
High risk HPV
Squamous cell carc of vag, adenocarc of cervix
ionizing radiation
AML, CML, papillary carc of thyroid—>hydroxyl free radicals
NONionizing radiation
UVB–>basal cell, squamous cell, melanoma00>pyrimidine dimers
func of CDK4
CDK phosphorylates RB—> promotes cell cycle going thru G1/S checkpt
-mutation= melanoma
RAS-GDP
inactive
GTPase
if no GTPase, RAS cant shut off GTP so get too much growth
CND1
make sure cell goes G1 to S without mutations
p53
g1–>s regulation and upregs DNA repair enzymes (BAX)
BAX
disrputs BCL2 and now cytC leaks out and activates apop.
Rb
G1—>S
-if RB mutated, lots of E2F around and get too much growth
E2F transcription factor
goes to S phase
-E2F is released when Rb is phosphorylated by CDK4
role of BCL2
stabilize mito mem so nothing leaks
-bcl2 overexpressed in follicular lymphoma
pdgf overexpressed
astrocytoma
RET point mutation
medullary carc of thyroid
KIT point mutation
GI stromal tumor